Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation
被引:25
|
作者:
Laryea, Marie A.
论文数: 0引用数: 0
h-index: 0
机构:
Dalhousie Univ, Multiorgan Transplant Program, Halifax, NS, CanadaMayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
Laryea, Marie A.
[2
]
Watt, Kymberly D.
论文数: 0引用数: 0
h-index: 0
机构:
Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USAMayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
Watt, Kymberly D.
[1
]
机构:
[1] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
The reinfection of the hepatic allograft with hepatitis B virus and hepatitis C virus can have important sequelae that result in poor long-term patient and graft survival. Although a response to treatment with antiviral medications can improve these outcomes, not all patients tolerate these medications or experience viral eradication. Avoiding reinfection of the graft is the most effective means of improving the long-term outcomes for these patient populations. This review is focused on the prevention of viral hepatitis reinfection after liver transplantation. Liver Transpl, 2012. (C) 2012 AASLD.
机构:
Univ Michigan, Hlth Syst, Div Gastroenterol, Taubman Ctr 3912, Ann Arbor, MI 48109 USAUniv Michigan, Hlth Syst, Div Gastroenterol, Taubman Ctr 3912, Ann Arbor, MI 48109 USA